Cargando…
COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries
Autores principales: | Khan, Zakir, Karataş, Yusuf, Rahman, Hazir, Qayum, Mughal, Alzahrani, Khalid Jamaan, Kashif, Syed Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185190/ http://dx.doi.org/10.1016/j.phclin.2021.06.001 |
Ejemplares similares
-
Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020) -
Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022) -
Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action
por: Khan, Zakir, et al.
Publicado: (2020) -
Evaluation of health care professionals’ knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study
por: Khan, Zakir, et al.
Publicado: (2023) -
Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
por: Menang, Olga, et al.
Publicado: (2023)